Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
ZIVO Bioscience, Inc. (ZIVO) had Cash Flow from Financial Activities of $1.81M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.12M |
|
$-9.89M |
|
$0.08M |
|
$0.04M |
|
$9.97M |
|
$-9.85M |
|
$-0.04M |
|
$-9.89M |
|
$-9.89M |
|
$-9.89M |
|
$-9.89M |
|
$-9.89M |
|
$-9.89M |
|
$-9.85M |
|
$-7.10M |
|
3.82M |
|
3.82M |
|
$-2.59 |
|
$-2.59 |
|
| Balance Sheet Financials | |
$0.40M |
|
-- |
|
$0.26M |
|
$0.66M |
|
$4.21M |
|
-- |
|
$0.20M |
|
$4.41M |
|
$-3.75M |
|
$-3.75M |
|
$-3.75M |
|
3.95M |
|
| Cash Flow Statement Financials | |
$-3.29M |
|
-- |
|
|
Cash Flow from Financial Activities |
$1.81M |
$1.54M |
|
$0.07M |
|
$-1.47M |
|
$2.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-- |
|
-0.10 |
|
33.55% |
|
-8278.84% |
|
-8278.84% |
|
-5964.86% |
|
-8311.11% |
|
-8311.12% |
|
$-3.29M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.30 |
|
-- |
|
-- |
|
263.93% |
|
263.93% |
|
-1490.71% |
|
263.93% |
|
$-0.95 |
|
$-0.86 |
|
$-0.86 |
|